Skip to main content
Top
Published in: Diabetologia 10/2004

01-10-2004 | Article

High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in Type 1 diabetic pregnancies

Authors: K. Teramo, M. A. Kari, M. Eronen, H. Markkanen, V. Hiilesmaa

Published in: Diabetologia | Issue 10/2004

Login to get access

Abstract

Aims/hypothesis

In this study we investigated whether chronic fetal hypoxia, as indicated by amniotic fluid erythropoietin levels, is associated with perinatal morbidity in Type 1 diabetic pregnancies.

Methods

A total of 331 women with Type 1 diabetes had at least one childbirth between 1995 and 2000. The amniotic fluid erythropoietin concentration was measured in 156 diabetic singleton pregnancies at a median time of 1 day before Caesarean section without labour contractions and in 19 healthy control subjects at Caesarean section.

Results

The median amniotic fluid erythropoietin level was 14.0 mU/ml (range 2.0–1975.0) in diabetic pregnancies and 6.3 mU/ml (range 1.7–13.7) in controls (p<0.0001). Of the 156 diabetic patients, 21 (13.5%) had amniotic fluid erythropoietin levels higher than 63.0 mU/ml. Amniotic fluid erythropoietin levels correlated negatively with umbilical artery pH (r=−0.49, p<0.0001) and pO2 (r=−0.62, p<0.0001) at birth and neonatal lowest blood glucose level (r=−0.47, p<0.0001). Positive correlations were found between amniotic fluid erythropoietin levels and umbilical artery pCO2 (r=0.49, p<0.0001) and last maternal HbA1c (r=0.43, p<0.0001). Furthermore, a U-shaped correlation was demonstrated between amniotic fluid erythropoietin levels and birthweight z score (z score below −0.6 SD units: r=−0.63, p=0.0007; z score above +1.0 SD units: r=0.32, p=0.0014). Neonatal hypoglycaemia, hypertrophic cardiomyopathy and admission to the neonatal intensive care unit occurred significantly more often in cases with high amniotic fluid erythropoietin levels (>63.0 mU/ml) than in those with normal levels. Multivariate logistic regression analysis revealed that amniotic fluid erythropoietin was the only variable independently related to low umbilical artery pH (<7.21; p<0.0001) and neonatal hypoglycaemia (p=0.002). Low umbilical artery pO2 (<15.0 mm Hg) was explained by amniotic fluid erythropoietin (p<0.0001) and birthweight z score (p=0.004).

Conclusions/interpretation

Antenatal high amniotic fluid erythropoietin levels can identify Type 1 diabetic pregnancies at increased risk of severe perinatal complications.
Literature
1.
go back to reference Mimouni F, Miodovnik M, Siddiqi TA, Khoury J, Tsang RC (1988) Perinatal asphyxia in infants of insulin-dependent diabetic mothers. J Pediatr 113:345–353PubMed Mimouni F, Miodovnik M, Siddiqi TA, Khoury J, Tsang RC (1988) Perinatal asphyxia in infants of insulin-dependent diabetic mothers. J Pediatr 113:345–353PubMed
2.
go back to reference Salvesen DR, Brudenell JM, Snijders RJM, Ireland RM, Nicolaides KH (1993) Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol 168:88–94PubMed Salvesen DR, Brudenell JM, Snijders RJM, Ireland RM, Nicolaides KH (1993) Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol 168:88–94PubMed
3.
go back to reference Widness JA, Susa JB, Garcia JF et al. (1981) Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and hyperinsulinemic rhesus fetuses. J Clin Invest 67:637–642PubMed Widness JA, Susa JB, Garcia JF et al. (1981) Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and hyperinsulinemic rhesus fetuses. J Clin Invest 67:637–642PubMed
4.
go back to reference Teramo KA, Widness JA, Clemons GK, Voutilainen P, McKinlay S, Schwartz R (1987) Amniotic fluid erythropoietin correlates with umbilical plasma erythropoietin in normal and abnormal pregnancy. Obstet Gynecol 69:710–716PubMed Teramo KA, Widness JA, Clemons GK, Voutilainen P, McKinlay S, Schwartz R (1987) Amniotic fluid erythropoietin correlates with umbilical plasma erythropoietin in normal and abnormal pregnancy. Obstet Gynecol 69:710–716PubMed
5.
go back to reference Mimouni F, Miodovnik M, Siddiqi TA, Butler JB, Holroyde J, Tsang R (1986) Neonatal polycythemia in infants of insulin-dependent diabetic mothers. Obstet Gynecol 68:370–372PubMed Mimouni F, Miodovnik M, Siddiqi TA, Butler JB, Holroyde J, Tsang R (1986) Neonatal polycythemia in infants of insulin-dependent diabetic mothers. Obstet Gynecol 68:370–372PubMed
6.
go back to reference Cordero L, Treuer SH, Landon MB, Gabbe SG (1998) Management of infants of diabetic mothers. Arch Pediatr Adolesc Med 152:249–254PubMed Cordero L, Treuer SH, Landon MB, Gabbe SG (1998) Management of infants of diabetic mothers. Arch Pediatr Adolesc Med 152:249–254PubMed
7.
go back to reference Petry CD, Eaton MA, Wobken JD, Mills MM, Johnson DE, Georgieff MK (1992) Iron deficiency of liver, heart, and brain in newborn infants of diabetic mothers. J Pediatr 121:109–114PubMed Petry CD, Eaton MA, Wobken JD, Mills MM, Johnson DE, Georgieff MK (1992) Iron deficiency of liver, heart, and brain in newborn infants of diabetic mothers. J Pediatr 121:109–114PubMed
8.
go back to reference Voutilainen PEJ, Widness JA, Clemons GK, Schwartz R, Teramo KA (1989) Amniotic fluid erythropoietin predicts fetal distress in Rh-immunized pregnancies. Am J Obstet Gynecol 160:429–434PubMed Voutilainen PEJ, Widness JA, Clemons GK, Schwartz R, Teramo KA (1989) Amniotic fluid erythropoietin predicts fetal distress in Rh-immunized pregnancies. Am J Obstet Gynecol 160:429–434PubMed
9.
go back to reference Westgren M, Ek S, Remberger M, Ringden O, Stangenberg M (1995) Cytokine in fetal blood and amniotic fluid in Rh-immunized pregnancies. Obstet Gynecol 86:209–213CrossRefPubMed Westgren M, Ek S, Remberger M, Ringden O, Stangenberg M (1995) Cytokine in fetal blood and amniotic fluid in Rh-immunized pregnancies. Obstet Gynecol 86:209–213CrossRefPubMed
10.
go back to reference Buescher U, Hertwig K, Wolf C, Dudenhausen JW (1998) Erythropoietin in amniotic fluid as a marker of chronic fetal hypoxia. Int J Gynecol Obstet 60:257–263CrossRef Buescher U, Hertwig K, Wolf C, Dudenhausen JW (1998) Erythropoietin in amniotic fluid as a marker of chronic fetal hypoxia. Int J Gynecol Obstet 60:257–263CrossRef
11.
go back to reference Widness JA, Schmidt RL, Sawyer ST (1995) Erythropoietin transplacental passage—review of animal studies. J Perinat Med 23:61–70PubMed Widness JA, Schmidt RL, Sawyer ST (1995) Erythropoietin transplacental passage—review of animal studies. J Perinat Med 23:61–70PubMed
12.
go back to reference Maier RF, Böhme K, Dudenhausen JW, Obladen M (1993) Cord blood erythropoietin in relation to different markers of fetal hypoxia. Obstet Gynecol 81:575–580PubMed Maier RF, Böhme K, Dudenhausen JW, Obladen M (1993) Cord blood erythropoietin in relation to different markers of fetal hypoxia. Obstet Gynecol 81:575–580PubMed
13.
go back to reference Rollins MD, Maxwell AP, Afrasiabi M, Halliday HL, Lappin TRJ (1993) Cord blood erythropoietin, pH, PaO2 and haematocrit following caesarean section before labour. Biol Neonate 63:147–152PubMed Rollins MD, Maxwell AP, Afrasiabi M, Halliday HL, Lappin TRJ (1993) Cord blood erythropoietin, pH, PaO2 and haematocrit following caesarean section before labour. Biol Neonate 63:147–152PubMed
14.
go back to reference Widness JA, Clemons GK, Garcia JF, Oh W, Schwartz R (1984) Increased immunoreactive erythropoietin in cord serum after labor. Am J Obstet Gynecol 148:194–197PubMed Widness JA, Clemons GK, Garcia JF, Oh W, Schwartz R (1984) Increased immunoreactive erythropoietin in cord serum after labor. Am J Obstet Gynecol 148:194–197PubMed
15.
go back to reference Pihkala J, Hakala T, Voutilainen P, Raivio K (1989) New Finnish fetal growth curves [article in Finnish]. Duodecim 105:1540–1546PubMed Pihkala J, Hakala T, Voutilainen P, Raivio K (1989) New Finnish fetal growth curves [article in Finnish]. Duodecim 105:1540–1546PubMed
16.
go back to reference Allan L (2000) M-mode echocardiography. In: Allan L, Hornberger L, Sharland G (eds) Textbook of fetal cardiology, 1st edn. Greenwich Medical Media, London, pp 95–102 Allan L (2000) M-mode echocardiography. In: Allan L, Hornberger L, Sharland G (eds) Textbook of fetal cardiology, 1st edn. Greenwich Medical Media, London, pp 95–102
17.
go back to reference Madsen H (1986) Fetal oxygenation in diabetic pregnancy. Danish Med Bull 33:64–74PubMed Madsen H (1986) Fetal oxygenation in diabetic pregnancy. Danish Med Bull 33:64–74PubMed
18.
go back to reference Carson BS, Philipps AF, Simmons MA, Battaglia FC, Meschia G (1980) The effects of sustained insulin infusion upon glucose uptake and oxygenation in the ovine fetus. Pediatr Res 14:147–152PubMed Carson BS, Philipps AF, Simmons MA, Battaglia FC, Meschia G (1980) The effects of sustained insulin infusion upon glucose uptake and oxygenation in the ovine fetus. Pediatr Res 14:147–152PubMed
19.
go back to reference Philipps AF, Widness JA, Garcia JF, Raye JR, Schwartz R (1982) Erythropoietin elevation in the chronically hyperglycemic fetal lamb. Proc Soc Exp Biol Med 170:42–47PubMed Philipps AF, Widness JA, Garcia JF, Raye JR, Schwartz R (1982) Erythropoietin elevation in the chronically hyperglycemic fetal lamb. Proc Soc Exp Biol Med 170:42–47PubMed
20.
go back to reference Milley JR, Rosenberg AA, Philipps AF, Molteni RA, Jones MD, Simmons MA (1984) The effect of insulin on ovine fetal oxygen extraction. Am J Obstet Gynecol 149:673–678PubMed Milley JR, Rosenberg AA, Philipps AF, Molteni RA, Jones MD, Simmons MA (1984) The effect of insulin on ovine fetal oxygen extraction. Am J Obstet Gynecol 149:673–678PubMed
21.
go back to reference Widness JA, Teramo KA, Clemons GK et al. (1990) Direct relationship of antepartum glucose control and fetal erythropoietin in human Type 1(insulin-dependent) diabetic pregnancy. Diabetologia 33:378–383PubMed Widness JA, Teramo KA, Clemons GK et al. (1990) Direct relationship of antepartum glucose control and fetal erythropoietin in human Type 1(insulin-dependent) diabetic pregnancy. Diabetologia 33:378–383PubMed
22.
go back to reference Hagbard L (1956) Pregnancy and diabetes mellitus; a clinical study. Acta Obstet Gynecol Scand 35 [Suppl 1]:1–180 Hagbard L (1956) Pregnancy and diabetes mellitus; a clinical study. Acta Obstet Gynecol Scand 35 [Suppl 1]:1–180
23.
go back to reference Lauenborg J, Mathiesen E, Ovesen P et al. (2003) Audit on stillbirths in women with pregestational Type 1 diabetes. Diabetes Care 26:1385–1389PubMed Lauenborg J, Mathiesen E, Ovesen P et al. (2003) Audit on stillbirths in women with pregestational Type 1 diabetes. Diabetes Care 26:1385–1389PubMed
24.
go back to reference Casson IF, Clarke CA, Howard CV et al. (1997) Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 315:275–278PubMed Casson IF, Clarke CA, Howard CV et al. (1997) Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 315:275–278PubMed
25.
go back to reference Kjos SL, Leung A, Henry OA, Victor MR, Paul RH, Medearis AL (1995) Antepartum surveillance in diabetic pregnancies: predictors of fetal distress in labor. Am J Obstet Gynecol 173:1532–1539CrossRefPubMed Kjos SL, Leung A, Henry OA, Victor MR, Paul RH, Medearis AL (1995) Antepartum surveillance in diabetic pregnancies: predictors of fetal distress in labor. Am J Obstet Gynecol 173:1532–1539CrossRefPubMed
26.
go back to reference Widness JA, Teramo KA, Clemons GK et al. (1986) Temporal response of immunoreactive erythropoietin to acute hypoxemia in fetal sheep. Pediatr Res 20:15–19PubMed Widness JA, Teramo KA, Clemons GK et al. (1986) Temporal response of immunoreactive erythropoietin to acute hypoxemia in fetal sheep. Pediatr Res 20:15–19PubMed
27.
go back to reference Kakuya F, Shirai M, Takase M, Ishii N, Okuno A (1997) Effect of hypoxia on amniotic fluid erythropoietin levels in fetal rats. Biol Neonate 72:118–124PubMed Kakuya F, Shirai M, Takase M, Ishii N, Okuno A (1997) Effect of hypoxia on amniotic fluid erythropoietin levels in fetal rats. Biol Neonate 72:118–124PubMed
28.
go back to reference Meschia G (1979) Supply of oxygen to the fetus. J Reprod Med 23:160–165PubMed Meschia G (1979) Supply of oxygen to the fetus. J Reprod Med 23:160–165PubMed
29.
go back to reference Teramo KA, Hiilesmaa VK, Schwartz R, Clemons GK, Widness JA (2004) Amniotic fluid and cord plasma erythropoietin levels in pregnancies complicated by preeclampsia, pregnancy-induced hypertension and chronic hypertension. J Perinat Med 32:240–247CrossRefPubMed Teramo KA, Hiilesmaa VK, Schwartz R, Clemons GK, Widness JA (2004) Amniotic fluid and cord plasma erythropoietin levels in pregnancies complicated by preeclampsia, pregnancy-induced hypertension and chronic hypertension. J Perinat Med 32:240–247CrossRefPubMed
30.
go back to reference Chong ZZ, Kang JQ, Maiese K (2002) Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Blood Flow Metab 22:503–514CrossRefPubMed Chong ZZ, Kang JQ, Maiese K (2002) Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Blood Flow Metab 22:503–514CrossRefPubMed
31.
go back to reference Sirén AL, Fratelli M, Goemans C et al. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 98:4044–4049CrossRefPubMed Sirén AL, Fratelli M, Goemans C et al. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 98:4044–4049CrossRefPubMed
32.
go back to reference Ehrenreich H, Hasselblatt M, Dembowski C et al. (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8:495–505PubMed Ehrenreich H, Hasselblatt M, Dembowski C et al. (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8:495–505PubMed
Metadata
Title
High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in Type 1 diabetic pregnancies
Authors
K. Teramo
M. A. Kari
M. Eronen
H. Markkanen
V. Hiilesmaa
Publication date
01-10-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1515-3

Other articles of this Issue 10/2004

Diabetologia 10/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.